Biotech Values

[drbio45]

achn

you actually worry too much about dilution.

If they raise a lot of money the stock will be able to go up because they will have enough money to progress the drugs further. If the drugs show good results the Hep C market is big enough to maintain a high market cap.

The writing was on the wall that this financing was going to get done. I do mot know why the didn't do a quick deal when the stock was in the three's

Dew, I see that you are saying that they attempted to get the deal done in the three's. I am not so sure about that